Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Occurrence of atrial fibrillation (AF) amongst bisphosphonate users has been increasingly reported but results are conflicting. We performed a Bayesian meta-analysis to address the possible association between the occurrence of AF and bisphosphonate use and estimated the posterior probability of development of AF with bisphosphonate use. METHODS: Randomized controlled trials (RCTs) evaluating the efficacy and safety of bisphosphonates for treating and preventing osteoporosis, and observational studies investigating the incidence of AF amongst bisphosphonate users, were searched in electronic databases. We pooled the effect size with Bayesian meta-analysis for odds ratio (OR) and calculated its posterior probability of development of AF in bisphosphonate users for RCTs and observational studies, reported with the 95% credible interval (CI). RESULTS: Of 1751 potentially relevant citations initially retrieved, 4 RCTs and 2 reports of RCTs, and 3 observational studies were included for this meta-analysis. On pooling the RCTs, there was a non-significantly higher risk of overall (OR 1.184, 95% CI 0.837-1.656) and serious AF (OR 1.590, 95% CI 0.613-3.751) in bisphosphonate-treated patients. Combining data of observational studies also revealed a non-significantly higher risk of AF in bisphosphonate users (OR 1.251, 95% CI 0.980-1.732). Using Bayesian meta-analysis based on the effect size of observational studies as the prior, the posterior probability of OR>1.2 in the development of AF amongst bisphosphonate users in the RCTs was 0.484. Egger's regression demonstrated no notable publication bias in all the analyses. CONCLUSION: The current meta-analysis revealed no evidence of a higher risk of AF associated with bisphosphonate use. Nevertheless, based on Bayesian meta-analysis with the effect size of the observational studies as the prior, the posterior probabilities of development of AF was found to be 0.484 if the risk of AF was estimated to be more than 20%. The results of the current meta-analysis thus offer clinicians the practical probability of development of AF in patients who take bisphosphonates for the treatment of bone loss and corticosteroid induced osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986 · cited 14×
“We therefore decided that rather than combining all the results of the RCTs, it would be more appropriate to perform a sensitivity analysis to test the robustness of the result of the 4 RCTs (the HORIZON Pivotal Fracture Trial, the HORIZON Recurrent Fracture Trial and the other is a report of the 2 FIT) by comparing w…”
BackgroundResultInfluentialMeta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 13×
“We therefore decided that rather than combining all the results of the RCTs, it would be more appropriate to perform a sensitivity analysis to test the robustness of the result of the 4 RCTs (the HORIZON Pivotal Fracture Trial, the HORIZON Recurrent Fracture Trial and the other is a report of the 2 FIT) by comparing w…”
BackgroundMethodResultInfluentialZoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 12×
“We therefore decided that rather than combining all the results of the RCTs, it would be more appropriate to perform a sensitivity analysis to test the robustness of the result of the 4 RCTs (the HORIZON Pivotal Fracture Trial, the HORIZON Recurrent Fracture Trial and the other is a report of the 2 FIT) by comparing w…”
BackgroundResultInfluentialInflammation as a risk factor for atrial fibrillation
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103131.70301.4f · Cited by 1,425 · cited 1×
“These inflammatory cytokines may cause remodelling of the atrium, tissue organisation, fibrosis and subsequent development of AF [38,39].”
BackgroundReginster, J.-Y., Adami, S., Lakatos, P., Greenwald, M., Stepan, J. J., Silverman, S. L., Christiansen, C., Rowell, L., Mairon, N., Bonvoisin, B., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044958 · Cited by 326
Cited by
Anglemyer, A., Horvath, H. T., & Bero, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000034.pub2 · Cited by 534
Conducting a meta-analysis: Basics and good practices
Cheung, M. W. ‐., Ho, R. C. M., Lim, Y., & Mak, A. (2012) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2012.01712.x · Cited by 172
Self-citationAge-Dependent Effect of β-Blockers in Preventing Vasovagal Syncope
Sheldon, R. S., Morillo, C. A., Klingenheben, T., Krahn, A. D., Sheldon, A., & Rose, M. S. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.112.974386 · Cited by 72
Toews, I., Anglemyer, A., Nyirenda, J. L., Alsaid, D., Balduzzi, S., Grummich, K., Schwingshackl, L., & Bero, L. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000034.pub3 · Cited by 60
Metadata
- Authors
- Mak, A., Cheung, M. W., Ho, R. C.-M., Cheak, A. A.-C., & Lau, C. S.
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2009-09-21
- Volume
- 10
- Issue
- 1
- Pages
- 113-113
- ISSN
- 1471-2474 (ISSN-L)
- OpenAlex
- W1976757447
- Cited by
- 77
- References
- 7
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies. https://app.cochat.ai/papers/10.1186/1471-2474-10-113
- The paper
- Mak, A., Cheung, M. W., Ho, R. C.-M., Cheak, A. A.-C., & Lau, C. S. (2009). Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies. BMC Musculoskeletal Disorders. https://doi.org/10.1186/1471-2474-10-113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.